Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Caplin Point Laboratories LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524742 P/E (TTM) :35.65
ISIN Demat:INE475E01026 Div & Yield %:0.35 EPS (TTM) :47.66
Book Value (RS) :242.5445604 Market Cap (Rs Cr.):12913.25 Face Value (RS) :2
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.000.000.000.000.00
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio4.123.163.574.824.45
Fixed Assets2.152.071.911.971.95
Inventory9.879.0711.2115.6020.44
Debtors4.955.767.456.943.04
Interest Cover Ratio3681.583658.402443.922782.221235.94
PBIDTM (%)62.0162.8660.3352.3048.18
PBITM (%)58.7258.5355.4847.4243.53
PBDTM (%)61.9962.8460.3152.2848.14
CPM (%)48.4149.7249.1740.4637.02
APATM (%)45.1245.3944.3235.5832.37
ROCE (%)28.5028.8428.2429.5030.68
RONW (%)21.9722.4322.6322.2423.00

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)